Allspring Global Investments Holdings, LLC Neurocrine Biosciences Inc Transaction History

Allspring Global Investments Holdings, LLC

$59.3 Billion
Q4 2024

A detailed history of Allspring Global Investments Holdings, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 480,565 shares of NBIX stock, worth $73.2 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

480,565

Previous 689,986 30.35%

Holding current value

$73.2 Million

Previous $79.4 Million 17.42%

% of portfolio

0.11%

Previous 0.13%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	SELL	$111.62 - $139.44 $23.4 Million - $29.2 Million	-209,421 Reduced 30.35%	480,565 $65.6 Million
Q3 2024 Oct 18, 2024	SELL	$114.58 - $153.15 $2.36 Million - $3.16 Million	-20,614 Reduced 2.9%	689,986 $79.4 Million
Q2 2024 Jul 26, 2024	BUY	$130.86 - $143.19 $26.7 Million - $29.2 Million	203,934 Added 40.25%	710,600 $97.8 Million
Q1 2024 Apr 18, 2024	BUY	$130.4 - $143.74 $12.6 Million - $13.9 Million	96,563 Added 23.55%	506,666 $69.9 Million
Q4 2023 Jan 25, 2024	BUY	$106.07 - $132.76 $19.6 Million - $24.5 Million	184,660 Added 81.91%	410,103 $54 Million
Q3 2023 Oct 27, 2023	BUY	$94.02 - $117.1 $21.2 Million - $26.4 Million	225,443 New	225,443 $25.4 Million
Q2 2023 Jul 18, 2023	BUY	$89.53 - $104.87 $2.83 Million - $3.31 Million	31,590 Added 9.35%	369,604 $34.9 Million
Q1 2023 Apr 13, 2023	SELL	$94.11 - $123.02 $14.9 Million - $19.5 Million	-158,179 Reduced 31.88%	338,014 $34.2 Million
Q4 2022 Jan 23, 2023	SELL	$106.72 - $127.06 $4.57 Million - $5.44 Million	-42,846 Reduced 7.95%	496,193 $0
Q3 2022 Oct 26, 2022	BUY	$92.03 - $107.81 $39.3 Million - $46 Million	426,675 Added 379.73%	539,039 $57.3 Million
Q2 2022 Jul 25, 2022	SELL	$75.79 - $100.07 $6.85 Million - $9.05 Million	-90,391 Reduced 44.58%	112,364 $11 Million
Q1 2022 May 02, 2022	SELL	$72.45 - $94.81 $167,431 - $219,105	-2,311 Reduced 1.13%	202,755 $19 Million
Q4 2021 Jan 28, 2022	BUY	$79.65 - $106.22 $16.3 Million - $21.8 Million	205,066 New	205,066 $17.5 Million

Others Institutions Holding NBIX

# of Institutions

639

Shares Held

94.1M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14.6B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account

Allspring Global Investments Holdings, LLC Neurocrine Biosciences Inc Transaction History